These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2818565)

  • 1. Calmodulin antagonist action in smooth-muscle myosin phosphorylation. Different mechanisms for trifluoperazine and calmidazolium inhibition.
    Sobieszek A
    Biochem J; 1989 Aug; 262(1):215-23. PubMed ID: 2818565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme kinetic characterization of the smooth muscle myosin phosphorylating system: activation by calcium and calmodulin and possible inhibitory mechanisms of antagonists.
    Sobieszek A
    Biochim Biophys Acta; 1999 May; 1450(1):77-91. PubMed ID: 10231558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vectorial phosphorylation of filamentous smooth muscle myosin by calmodulin and myosin light chain kinase complex.
    Sobieszek A
    J Muscle Res Cell Motil; 2001; 22(6):505-11. PubMed ID: 12038584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle.
    Asano M
    J Pharmacol Exp Ther; 1989 Nov; 251(2):764-73. PubMed ID: 2810127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin antagonists inhibit activity of myosin light-chain kinase independent of calmodulin.
    Zimmer M; Hofmann F
    Eur J Biochem; 1984 Jul; 142(2):393-7. PubMed ID: 6547673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle myosin as a calmodulin binding protein. Affinity increase on filament assembly.
    Sobieszek A
    J Muscle Res Cell Motil; 1990 Apr; 11(2):114-24. PubMed ID: 2351749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse actions of cadmium on the smooth muscle myosin phosphorylation system.
    Kostrzewska A; Sobieszek A
    FEBS Lett; 1990 Apr; 263(2):381-4. PubMed ID: 2335243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of myosin filament activation by telokin in smooth muscle liberation of myosin kinase and phosphatase from supramolecular complexes.
    Sobieszek A; Andruchov OY; Grabarek Z; Kulikova N; Liebetrau C; Matusovsky OS
    Biophys Chem; 2005 Jan; 113(1):25-40. PubMed ID: 15617808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of smooth muscle myosin light chain kinase. Allosteric effects and co-operative activation by calmodulin.
    Sobieszek A
    J Mol Biol; 1991 Aug; 220(4):947-57. PubMed ID: 1880806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine inhibits the MgATPase activity and in vitro motility of conventional and unconventional myosins.
    Sellers JR; Wang F; Chantler PD
    J Muscle Res Cell Motil; 2003; 24(8):579-85. PubMed ID: 14870973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vectorial activation of smooth muscle myosin filaments and its modulation by telokin.
    Sobieszek A
    Can J Physiol Pharmacol; 2005 Oct; 83(10):899-912. PubMed ID: 16333362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca(2+)-calmodulin-dependent modification of smooth-muscle myosin light-chain kinase leading to its co-operative activation by calmodulin.
    Sobieszek A; Strobl A; Ortner B; Babiychuk EB
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):405-11. PubMed ID: 8240237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    Silver PJ; Stull JT
    Mol Pharmacol; 1983 May; 23(3):665-70. PubMed ID: 6688120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of vascular and cardiac contractile protein regulatory mechanisms by calmodulin inhibitors and related compounds.
    Silver PJ; Pinto PB; Dachiw J
    Biochem Pharmacol; 1986 Aug; 35(15):2545-51. PubMed ID: 2943284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets.
    Holmsen H; Daniel JL; Dangelmaier CA; Molish I; Rigmaiden M; Smith JB
    Thromb Res; 1984 Dec; 36(5):419-28. PubMed ID: 6523448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of smooth muscle myosin light chain kinase and its modifications by melittin and calmodulin.
    Babiychuk EB; Sobieszek A
    Biopolymers; 1997 Nov; 42(6):673-86. PubMed ID: 9358732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin kinase of molluscan smooth muscle. Regulation by binding of calcium to the substrate and inhibition of myorod and twitchin phosphorylation by myosin.
    Sobieszek A; Sarg B; Lindner H; Matusovsky OS; Zukowska M
    Biochemistry; 2010 May; 49(19):4191-9. PubMed ID: 20402494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluoperazine inhibits the contraction of cultured rat cardiac cells and the phosphorylation of myosin light chain.
    Klein I
    J Clin Invest; 1983 Mar; 71(3):518-24. PubMed ID: 6826721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-induced myosin light-chain phosphorylation during receptor capping in IM-9 human B-lymphoblasts.
    Majercik MH; Bourguignon LY
    Biochem J; 1988 Jun; 252(3):815-23. PubMed ID: 3048249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin antagonists inhibit latch bridges in detergent skinned swine carotid media.
    Moreland S; Little DK; Moreland RS
    Am J Physiol; 1987 May; 252(5 Pt 1):C523-31. PubMed ID: 3495186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.